SCHEMBL20736273

SCHEMBL20736273

CC(C)(C)c1ccc(N(c2ccc3c4c(c5ccccc5c3c2)-c2ccc3ccccc3c2C42c3ccccc3-c3ccccc32)c2ccc3c4c(c5ccccc5c3c2)-c2ccc3ccccc3c2C42c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.31

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.31
▸ CYP2D6 P10635 2/20 0.31
▸ NR1I2 O75469 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ SIGMAR1 Q99720 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ ALOX12 P18054 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737566 0.96 — —
SCHEMBL20737443 0.95 LMNA (0.31) LMNACYP2D6NR1I2ADRA2AACHE
SCHEMBL20735767 0.94 GPR84 (0.30) —
SCHEMBL20737299 0.94 — —
SCHEMBL20736644 0.94 — —
SCHEMBL20736059 0.92 GPR84 (0.31) —
SCHEMBL20736271 0.90 SOS1 (0.35) LMNACYP2D6MEN1USP2ALDH1A1
SCHEMBL27250907 0.90 SOS1 (0.35) LMNACYP2D6MEN1USP2ALDH1A1
SCHEMBL20736272 0.89 MEN1 (0.32) LMNACYP2D6MEN1USP2ALDH1A1
SCHEMBL20736253 0.88 NR1I2 (0.33) LMNACYP2D6NR1I2ADRA2AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 — — US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 LMNA 1778/4885CYP2D6 1828/4885NR1I2 1371/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 LMNA 1778/4885CYP2D6 1828/4885NR1I2 1371/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 LMNA 1778/4885CYP2D6 1828/4885NR1I2 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback